Evaluation of the anti-inflammatory and antinociceptive activities of the synthetic compound ((2S,6S)-6-ethyl-tetrahydro-2H-pyran-2-yl)methanol in mice
Tetrahydropyran derivatives, acute inflammation, mice, cytokines, acute nociception.
In recent years, the main objective of research related to pain treatment has been to develop new substances with greater efficacy and less toxicity than currently available drugs, and which have a lower economic cost. Therefore, there has been a great interest of researchers in the development of drugs based on molecular improvement strategies. Inflammatory affections affect animals in a marked and progressive way, causing sometimes irreversible damage. Early therapeutic intervention and effective drugs to control symptoms and disease progression are essential for a positive prognosis. Inflammatory affections in Veterinary Medicine are commonly related to chronic pain, mobility impairment, dyspnea, diarrhea and intestinal malabsorption, which are related to a high degree of morbidity and mortality in the veterinary clinical routine. With this project, we intend to evaluate the activity of the compound ((2S,6S)-6-ethyl-tetrahydro-2H-pyran-2-yl)methanol, here called LS20, in relation to its analgesic and anti-inflammatory potential in models in vivo and in vitro, in addition to in vivo and in vitro toxicological evaluation for future clinical trials in companion animals and thus contributing to the development of pharmacology and veterinary therapy.